Soldi Gemma, Plakoutsi Georgia, Taddei Niccolo, Chiti Fabrizio
Dipartimento di Scienze Biochimiche, Università di Firenze, Viale Morgagni 50, 50134 Firenze, Italy.
J Med Chem. 2006 Oct 5;49(20):6057-64. doi: 10.1021/jm0606488.
The acylphosphatases from Sulfolobus solfataricus and Drosophila melanogaster (Sso AcP and AcPDro2) were previously shown to form amyloid-like aggregates without the need to unfold initially. Inorganic phosphate (Pi), a competitive inhibitor binding specifically to the active site of these proteins, was found to stabilize, upon binding, the native state of AcPDro2 and to inhibit its conversion into amyloid-like fibrils. The inhibitory effect of Pi is suppressed only in a variant in which the Arg residue responsible for Pi binding is mutated. The study on Sso AcP shows that Pi retards both the formation of the initial nativelike oligomers and their subsequent conversion into protofibrils. Thus, stabilization of the native structure mediated by specific binding with small molecules can be an effective therapeutic strategy against protein deposition diseases that originate from initially folded proteins, independently of the structure of the protein, its aggregation pathway, and the particular aggregated species responsible for pathogenesis.
先前的研究表明,来自嗜热栖热菌(Sulfolobus solfataricus)和黑腹果蝇(Drosophila melanogaster)的酰基磷酸酶(Sso AcP和AcPDro2)无需先展开就能形成淀粉样聚集体。无机磷酸盐(Pi)是一种特异性结合这些蛋白质活性位点的竞争性抑制剂,研究发现,Pi在结合后能稳定AcPDro2的天然状态,并抑制其转化为淀粉样纤维。只有在负责Pi结合的精氨酸残基发生突变的变体中,Pi的抑制作用才会被抑制。对Sso AcP的研究表明,Pi既能延缓最初类似天然状态的寡聚体的形成,也能延缓其随后转化为原纤维的过程。因此,通过与小分子特异性结合介导的天然结构稳定化可以成为一种有效的治疗策略,用于对抗源自初始折叠蛋白的蛋白质沉积疾病,而与蛋白质的结构、其聚集途径以及负责发病机制的特定聚集物种无关。